Genetic and pharmacologic inhibition of Skp2, an E3 ubiquitin ligase and RB1-target, has antitumor activity in RB1-deficient human and mouse small cell lung cancer (SCLC)

被引：0
|
作者：
Zhao, Hongling [1 ]
Sukrithan, Vineeth [1 ]
Iqbal, Niloy [1 ]
Nicholas, Cari [1 ]
Xue, Yingjiao [1 ]
Locker, Joseph [2 ]
Zou, Juntao [1 ]
Zhu, Liang [1 ]
Schwartz, Edward L. [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-1060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1060
引用
收藏
页数：2
相关论文
共 17 条
  • [1] Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer
    Zhao, Hongling
    Iqbal, Niloy J.
    Sukrithan, Vineeth
    Nicholas, Cari
    Xue, Yingjiao
    Yu, Cindy
    Locker, Joseph
    Zou, Juntao
    Schwartz, Edward L.
    Zhu, Liang
    [J]. CANCER RESEARCH, 2020, 80 (11) : 2355 - 2367
  • [2] Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition
    Gupta, Pranav
    Zhao, Hongling
    Hoang, Bang
    Schwartz, Edward L.
    [J]. BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 969 - 975
  • [3] Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition
    Pranav Gupta
    Hongling Zhao
    Bang Hoang
    Edward L. Schwartz
    [J]. British Journal of Cancer, 2022, 127 : 969 - 975
  • [4] Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity
    Zhonglei Lu
    Frederick Bauzon
    Hao Fu
    Jinhua Cui
    Hongling Zhao
    Keiko Nakayama
    Keiich I. Nakayama
    Liang Zhu
    [J]. Nature Communications, 5
  • [5] Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity
    Lu, Zhonglei
    Bauzon, Frederick
    Fu, Hao
    Cui, Jinhua
    Zhao, Hongling
    Nakayama, Keiko
    Nakayama, Keiich I.
    Zhu, Liang
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [6] Truncated E2F1 Radiosensitizes Prostate Cancer Cells by Inhibiting The E3 Ubiquitin Ligase SKP2
    Pollack, A.
    Udayakumar, T. S.
    Shareef, M. M.
    Ahmed, M. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S645 - S646
  • [7] The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2
    Jamal, Azfar
    Swarnalatha, Manickavinayaham
    Sultana, Sarwat
    Joshi, Prashant
    Panda, Subrat K.
    Kumar, Vijay
    [J]. CELL CYCLE, 2015, 14 (16) : 2688 - 2700
  • [8] Targeted inhibition of the E3 ligase SCFSkp2/Cks1 has survival benefit and antitumor activity in osteosarcoma
    Wang, Jichuan
    Ferrena, Alexander
    Zhang, Ranxin
    Singh, Swapnil
    Zhao, Hongling
    Zheng, Deyou
    Borjihan, Hasibagan
    Al-Harden, Waleed
    Tingling, Janet
    Yang, Rui
    Geller, David S.
    Hoang, Bang H.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [9] E3 ubiquitin-protein ligase 2 inhibits cell proliferation, migration, and invasion of non-small cell lung cancer through ubiquitination of Notch1
    Guo, Yuening
    Chi, Xiaowen
    Sun, Yu
    Liu, Jing
    Zhang, Lijuan
    Cao, Caihong
    Wang, Yansha
    Zhang, Wei
    Qu, Si'ying
    [J]. ACTA HISTOCHEMICA, 2022, 124 (01)
  • [10] C-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity
    Goto, E
    Ishido, S
    Sato, Y
    Ohgimoto, S
    Ohgimoto, K
    Nagano-Fujii, M
    Hotta, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) : 14657 - 14668
12